Last reviewed · How we verify
SF Easyhaler and charcoal
SF Easyhaler and charcoal is a Small molecule drug developed by Orion Corporation, Orion Pharma. It is currently in Phase 1 development.
At a glance
| Generic name | SF Easyhaler and charcoal |
|---|---|
| Sponsor | Orion Corporation, Orion Pharma |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Comparison of Salmeterol and Fluticasone Propionate Absorption From Salmeterol/Fluticasone Easyhaler With Seretide Diskus (PHASE1)
- Comparison of Salmeterol and Fluticasone Propionate Absorption From Salmeterol/Fluticasone Easyhaler and Seretide Diskus (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- SF Easyhaler and charcoal CI brief — competitive landscape report
- SF Easyhaler and charcoal updates RSS · CI watch RSS
- Orion Corporation, Orion Pharma portfolio CI
Frequently asked questions about SF Easyhaler and charcoal
What is SF Easyhaler and charcoal?
SF Easyhaler and charcoal is a Small molecule drug developed by Orion Corporation, Orion Pharma.
Who makes SF Easyhaler and charcoal?
SF Easyhaler and charcoal is developed by Orion Corporation, Orion Pharma (see full Orion Corporation, Orion Pharma pipeline at /company/orion-corporation-orion-pharma).
What development phase is SF Easyhaler and charcoal in?
SF Easyhaler and charcoal is in Phase 1.